Bisphosphonates as a Countermeasure to Space Flight Induced Bone Loss (Bisphosphonates) will determine whether antiresorptive agents, in conjunction with the routine inflight exercise program, will protect ISS crewmembers from the regional decreases in bone mineral density documented on previous ISS missions.
Bisphosphonates as a Countermeasure to Space Flight Induced Bone Loss
2009-01-01
Miscellaneous
No indication
English
Candidate Countermeasure against Bone Loss in Space
NTRS | 2017
|An Evidence-Based Countermeasure for Space Flight:...
AIAA | 2005
|British Library Conference Proceedings | 2008
|